Most mid‑market buyers run adequate financial and commercial diligence. They talk to customers and stress‑test the growth plan. Then they treat the technology as a line item under operational risk and move on.
That is where deals go wrong.
In a business where the product is software, or where delivery depends on systems and data, the technology is the business. A clean set of accounts tells you very little if the platform cannot carry the growth case or will cost three times the estimate to rebuild post‑close.
The question is: does this platform support the investment case at this price and on this timetable?
That shapes what you look at. If the thesis is organic growth through upsell, you want to know whether the product roadmap is credible and whether the current team can ship it. If the thesis is multiple bolt‑on acquisitions, you need to know how hard this platform is to integrate with. If it is margin expansion through automation, you need to know whether the infrastructure can actually deliver that, or whether it requires significant capital first.
The scope follows the decision. It does not follow a standard template.
What Actually Matters in Mid‑Market Deals
Mid‑market businesses are not smaller versions of large corporation targets. They often carry concentrated risk: a few key engineers, a product built on legacy code, a single cloud vendor with no fallback plan, or a security posture that has never been stress‑tested.
The questions that move value in these deals tend to cluster around five areas:
1. Can the architecture scale without a full rebuild and what would that rebuild cost?
2. Is there technical debt significant enough to slow delivery or inflate post‑close spend?
3. Are there security or resilience gaps that could interrupt revenue or create regulatory exposure?
4. How dependent is the business on one or two engineers and what is the succession plan?
5. How cleanly does this platform connect to your existing stack or planned integrations?
Each of these has a direct read‑through to valuation, deal structure or the first 100 days. They are not IT questions. They are investment questions.
Connect Tech Findings to Commercial and Financial Reality
The most common mistake is running tech diligence in a silo. An engineering team reviews the codebase and flags problems. The commercial team reviews the market and the customers. The financial team reviews the earnings. No one connects the three.
The commercial diligence says the growth plan assumes 40 new enterprise customers per year. The tech diligence says the platform requires a full re‑architecture to support multi‑tenancy at that scale and the team has no one who has built that before. Together, those findings change the valuation. Reviewed separately, neither is decisive.
The same applies to financial findings. If the EBITDA story assumes automation savings, those savings need to be grounded in what the platform can actually do and when. If the ARR quality review shows churn in a particular customer segment, the tech diligence should check whether product gaps are driving it.
Use Primary Research
Architecture diagrams tell you what the platform was designed to do. They do not tell you whether it does that reliably, what the team quietly knows is broken, or what customers are complaining about.
Interviews with engineering leads, product managers and key customers surface a different set of risks. Customers will often describe integration pain, reliability issues and missing features that do not appear in any data room document. Sector benchmarks help you judge whether the level of R&D spend and headcount is realistic for the plan on the table.
Primary research takes more time. It also tends to be where the deal‑relevant findings are.
Feed Tech Findings Into Valuation and Day One
Tech diligence that does not connect to deal terms or the post‑close plan has limited value. Good tech findings should produce concrete outputs: a capital expenditure adjustment to reflect platform investment needs, a specific first‑100‑day priority list built around stability, security and key hires and a clear position on integration complexity and timeline.
In mid‑market deals, the gap between reported value and delivered value often traces back to technology risks that were visible before close. The work is to find them early enough to act on them. Amberg Team scopes tech diligence to your investment thesis and the risks that matter.